Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.
Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W.
Cancer Lett. 2021 Mar 1;500:1-10. doi: 10.1016/j.canlet.2020.12.024. Epub 2020 Dec 23.
Osteosarcoma.
Ritter J, Bielack SS.
Ann Oncol. 2010 Oct;21 Suppl 7:vii320-5. doi: 10.1093/annonc/mdq276.
The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.
Corre I, Verrecchia F, Crenn V, Redini F, Trichet V.
Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976.
Translational biology of osteosarcoma.
Kansara M, Teng MW, Smyth MJ, Thomas DM.
Nat Rev Cancer. 2014 Nov;14(11):722-35. doi: 10.1038/nrc3838. Epub 2014 Oct 16.
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
Cersosimo F, Lonardi S, Bernardini G, Telfer B, Mandelli GE, Santucci A, Vermi W, Giurisato E.
Int J Mol Sci. 2020 Jul 23;21(15):5207. doi: 10.3390/ijms21155207.
Osteosarcoma in the Thyroid Gland.
Ijeoma B, Avadhani V, Zheng S, Moore C.
ORL J Otorhinolaryngol Relat Spec. 2023;85(1):52-56. doi: 10.1159/000525183. Epub 2022 Nov 1.
Targeting WNT5B and WNT10B in osteosarcoma.
Miranda-Carboni GA, Krum SA.
Oncotarget. 2024 Aug 2;15:535-540. doi: 10.18632/oncotarget.28617.
Radiotherapy in osteosarcoma.
Suit HD.
Clin Orthop Relat Res. 1975 Sep;(111):71-5. doi: 10.1097/00003086-197509000-00009.
Multidisciplinary approach to osteosarcoma.
Biazzo A, De Paolis M.
Acta Orthop Belg. 2016 Dec;82(4):690-698.
Monocytes, Macrophages, and Osteoclasts in Osteosarcoma.
Kelleher FC, O'Sullivan H.
J Adolesc Young Adult Oncol. 2017 Sep;6(3):396-405. doi: 10.1089/jayao.2016.0078. Epub 2017 Mar 6.
